Rapamycin used to prevent organ rejection after transplants and in cancer treatment was found to have anti-ageing effect and potential to treat COVID-19 patients.
Researchers from the biological control research foundation, Insilico Medicine, Life Extension and other institutions announced the landmark research on identifying metformin and rapamycin natural analogue in the Journal of aging.